PRESS RELEASE published on 02/09/2024 at 09:46, 9 months 12 days ago Original-Research: Netfonds AG (von NuWays AG): BUY Update on Netfonds AG by NuWays AG recommends BUY with a target price of €71.00. Anticipated favorable trends for 2024 include strong dollar, inflows into wealth management, money market fund opportunities, insurance broker market consolidation, and significant cross-selling potential Wealth Management Netfonds AG Buy Recommendation NuWays AG 2024 Trends
PRESS RELEASE published on 01/19/2024 at 09:02, 10 months 2 days ago Original-Research: Netfonds AG (von NuWays AG): BUY Netfonds AG has announced the acquisition of a majority stake in 'Meine Finanzkanzlei GmbH' through its subsidiary NVS Netfonds Versicherungsservice AG. This strategic move is expected to improve profitability and strengthen Netfonds' position in the market, particularly in the insurance division. The acquisition also paves the way for significant growth potential, as it enhances customer advice for affiliated banks. Coupled with Netfonds' proprietary 360° finfire platform and its leading position in a market with high entry barriers and long-term growth drivers, this development supports a BUY recommendation with a new price target of €71.00 based on DCF. Acquisition Profitability Netfonds AG Meine Finanzkanzlei GmbH Insurance Division
Published on 11/21/2024 at 13:30, 22 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 22 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 52 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 52 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 52 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 37 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 54 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 32 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo